ID: ALA4584813

Max Phase: Preclinical

Molecular Formula: C70H72N10O18S2

Molecular Weight: 1405.53

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-c2ccc(S(=O)(=O)N(CCNC(=O)CCCNC(=O)c3cccc(C(=O)NCCCC(=O)NCCN([C@H](CCN4C(=O)c5ccccc5C4=O)C(=O)NO)S(=O)(=O)c4ccc(-c5ccc(OC)cc5)cc4)c3)[C@H](CCN3C(=O)c4ccccc4C3=O)C(=O)NO)cc2)cc1

Standard InChI:  InChI=1S/C70H72N10O18S2/c1-97-51-26-18-45(19-27-51)47-22-30-53(31-23-47)99(93,94)79(59(65(85)75-91)34-40-77-67(87)55-12-3-4-13-56(55)68(77)88)42-38-71-61(81)16-8-36-73-63(83)49-10-7-11-50(44-49)64(84)74-37-9-17-62(82)72-39-43-80(100(95,96)54-32-24-48(25-33-54)46-20-28-52(98-2)29-21-46)60(66(86)76-92)35-41-78-69(89)57-14-5-6-15-58(57)70(78)90/h3-7,10-15,18-33,44,59-60,91-92H,8-9,16-17,34-43H2,1-2H3,(H,71,81)(H,72,82)(H,73,83)(H,74,84)(H,75,85)(H,76,86)/t59-,60-/m1/s1

Standard InChI Key:  DRXVUBODYFAEED-FNSAWIKJSA-N

Associated Targets(Human)

Matrix metalloproteinase 14 1592 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase 9 6779 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase-2 6627 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase-1 7046 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1405.53Molecular Weight (Monoisotopic): 1404.4467AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Cuffaro D, Nuti E, Gifford V, Ito N, Camodeca C, Tuccinardi T, Nencetti S, Orlandini E, Itoh Y, Rossello A..  (2019)  Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP).,  27  (1): [PMID:30522899] [10.1016/j.bmc.2018.11.041]

Source